{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2001"],"condition":["Colorectal Adenocarcinoma","Colorectal cancer","Colorectal Neoplasms"],"disease":["Colorectal Adenocarcinoma","Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2016896"],"location":["United States"],"study_start_month":["11"],"keyword":["Capecitabine","Thalidomide"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma","description":"The purpose of this study is to collect information about the antitumor activity and the safety of capecitabine and thalidomide in patients with colorectal cancer.","dates":{"creation":"2001-11-15"},"accession":"2016896","cross_references":{"ClinicalTrials___gov":["NCT00165217"]}}